Pain: Why sex matters
Pain cautions our bodies against harmful stimuli – such as a burning flame or the pointy end of a needle – and protects us when we are injured. These stimuli are detected by sensory neurons, which transmit signals to the spinal cord and brain. Damaging these neurons can lead to persistent and chronic pain, but the mechanisms underlying this are not fully understood.
One important player in controlling pain related to nerve damage is the immune system (Calvo et al., 2012; Scholz and Woolf, 2007). Previous work showed that injured sensory neurons release a protein called CSF1 (short for colony stimulating factor 1), which activates microglia, the main immune cell type in the brain and spinal cord. In this activated state, microglia proliferate, change their form and alter their behavior.
In 2016, a group of scientists discovered that male mice became hypersensitive to touch when their microglia were activated by nerve injury or by injecting CSF1 in to the space around the spinal cord (Guan et al., 2016). However, microglia have also been shown to be sexually dimorphic, playing different roles in disease and pain in males and females (Mogil, 2020). Now, in eLife, Allan Basbaum, Anna Molovsky and colleagues from the University of California, San Francisco – including Julia Kuhn and Ilia Vainchtein as co-first authors – report that microglia and another immune cell population respond differently to pain signals in male and female mice (Kuhn et al., 2021).
To investigate the mechanisms underlying hypersensitivity to touch, the team (which includes some of the researchers involved in the 2016 study) damaged the sciatic nerves of male and female mice lacking the gene for the CSF1 protein in their sensory neurons. Pain was assessed using the Von Frey assay, where mice are placed on an elevated grate and their paws are poked with different sized filaments (Decosterd and Woolf, 2000; Shields et al., 2003). Thick filaments will evoke a pain response that causes the mouse to flinch and withdraw its paw; whereas, thinner filaments only elicit this response when mice are hypersensitive to touch.
As shown previously, male mice deficient in CSF1 were not hypersensitive to touch after nerve injury. Female mice lacking CSF1, however, still withdrew their paws when poked with thinner filaments, suggesting that the mechanism underlying hypersensitivity in females is different to males. To confirm these findings, Kuhn et al. injected CSF1 near the spinal cord and assessed pain in the absence of nerve injury. As expected based on the previous results, the male mice became hypersensitive to touch, whereas the females did not (Figure 1). Further experiments examining the genes expressed by microglia after injection of CSF1 revealed that male mice upregulated different genes compared to females, including genes associated with disease, and the activation and recruitment of immune cells.
Other types of immune cells are known to influence how the central nervous system works under both normal and diseased conditions. To see if any of these might be involved in female pain sensation, Kuhn et al. examined which immune cells were present in the membrane layers surrounding the spinal cords of mice injected with CSF1. Females were found to have more regulatory T-cells, which are potent inflammation suppressors. Kuhn et al. wondered if having a greater number of regulatory T-cells counteracts the effects of CSF1, so they repeated the experiments in female mice in which regulatory T-cells had been depleted. This revealed that without regulatory T-cells, female mice also develop hypersensitivity after CSF1 injection, and their microglia express a more similar pattern of genes to the microglia of males (Figure 1).
This study demonstrates that the immune system plays different roles in the pain pathways of male and female mice after nerve injury. In male mice, microglia are the major immune cell type driving pain induced by CSF1 injection, while regulatory T-cells repress this pathway in females. This work highlights the need to include males and females in scientific research, and the importance of considering sex-specific approaches for pain management. It also opens up interesting questions for future investigation. For example, it is unclear how regulatory T-cells are recruited in females after CSF1 injection, and the mechanisms underlying pain hypersensitivity in female mice remain to be discovered.
References
-
The role of the immune system in the generation of neuropathic painThe Lancet. Neurology 11:629–642.https://doi.org/10.1016/S1474-4422(12)70134-5
-
Qualitative sex differences in pain processing: emerging evidence of a biased literatureNature Reviews. Neuroscience 21:353–365.https://doi.org/10.1038/s41583-020-0310-6
-
The neuropathic pain triad: neurons, immune cells and gliaNature Neuroscience 10:1361–1368.https://doi.org/10.1038/nn1992
Article and author information
Author details
Publication history
Copyright
© 2021, Wlaschin et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,538
- views
-
- 132
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
The concept that dimeric protein complexes in synapses can sequentially replace their subunits has been a cornerstone of Francis Crick’s 1984 hypothesis, explaining how long-term memories could be maintained in the face of short protein lifetimes. However, it is unknown whether the subunits of protein complexes that mediate memory are sequentially replaced in the brain and if this process is linked to protein lifetime. We address these issues by focusing on supercomplexes assembled by the abundant postsynaptic scaffolding protein PSD95, which plays a crucial role in memory. We used single-molecule detection, super-resolution microscopy and MINFLUX to probe the molecular composition of PSD95 supercomplexes in mice carrying genetically encoded HaloTags, eGFP, and mEoS2. We found a population of PSD95-containing supercomplexes comprised of two copies of PSD95, with a dominant 12.7 nm separation. Time-stamping of PSD95 subunits in vivo revealed that each PSD95 subunit was sequentially replaced over days and weeks. Comparison of brain regions showed subunit replacement was slowest in the cortex, where PSD95 protein lifetime is longest. Our findings reveal that protein supercomplexes within the postsynaptic density can be maintained by gradual replacement of individual subunits providing a mechanism for stable maintenance of their organization. Moreover, we extend Crick’s model by suggesting that synapses with slow subunit replacement of protein supercomplexes and long-protein lifetimes are specialized for long-term memory storage and that these synapses are highly enriched in superficial layers of the cortex where long-term memories are stored.
-
- Medicine
- Neuroscience
The advent of midazolam holds profound implications for modern clinical practice. The hypnotic and sedative effects of midazolam afford it broad clinical applicability. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain elusive. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, this in vivo research revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) represents a mechanistically crucial binding site in the LC for midazolam. These findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.